Liofilizowana nie sprasowana szybko dyspergująca stała postać dawkowania
- 专利权人:
- ALK-ABELLO A/S
- 发明人:
- HOUGHTON CHRISTIAN GAUGUIN,LUNDEGAARD ANNETTE ROEMMELMAYER,LUNDEGAARD ANNETTE RÖMMELMAYER
- 申请号：
- PL37854304
- 公开号：
- PL210707B1
- 申请日:
- 2004.02.24
- 申请国别(地区):
- PL
- 年份:
- 2012
- 代理人:
- 摘要：
- The present invention provides a non-compressed fast-dispersing solid dosage form suitable for oromucosal administration of a pharmaceutically active substance comprising (a) a first matrix forming agent in the form of maltodextrin having a dextrose equivalent (DE) of between 1 and 20,(b) a second matrix forming agent in the form of sorbitol, and (c) the active substance.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Solid oral dosage form comprising an immediate release particles comprising a Core with a First Active Agent, a Coating with a Second ACTIVE AGENT ON THE pH sensitive material and an Acid coated on Said Core； Preparing process； method of Treatment Slow； and use for treating pain.
- Solid oral dosage form of irinotecan for cancer treatment
- Oral capsule dosage forms include 0.1-3% glucose and 90-99% ligating or filling agents, which are 1:1-1:1.5 mixture of starch and manitol, as well as for the treatment or prevention or treatment of calcium, pain, disorders in the national chemical management system, etc.
- Solid oral dosage form Unitary Tablet comprising a Core and an outer coating, wherein the core comprises alisquireno or a Salt thereof, and Coating in a Coating Film, useful for the treatment of a disease or condition in a Pediatric population.
- DOSAGE AND ADMINISTRATION FOR PREVENTING CARDIOTOXICITY IN TREATMENT WITH ERBB2-TARGETED IMMUNOLIPOSOMES COMPRISING ANTHRACYCLIN CHEMOTHERAPEUTIC AGENTS
